United Therapeutics Corp banner

United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 568.43 USD 0.45%
Market Cap: $24.9B

Wall St Price Targets

UTHR Price Targets Summary
United Therapeutics Corp

Wall Street analysts forecast UTHR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for UTHR is 670.72 USD with a low forecast of 521.16 USD and a high forecast of 787.5 USD.

Lowest Forecast
Price Target
521.16 USD
8% Downside
Average Forecast
Price Target
670.72 USD
18% Upside
Highest Forecast
Price Target
787.5 USD
39% Upside
United Therapeutics Corp Competitors:
Price Targets
LGI
Lgi Ltd
31% Upside

Revenue
Forecast

10% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
10% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 10%.

Operating Income
Forecast

10% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
10% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 11%.

Net Income
Forecast

12% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
12% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 9%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is UTHR's stock price target?
Price Target
670.72 USD

According to Wall Street analysts, the average 1-year price target for UTHR is 670.72 USD with a low forecast of 521.16 USD and a high forecast of 787.5 USD.

What is the Revenue forecast for United Therapeutics Corp?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 10%.

What is the Operating Income forecast for United Therapeutics Corp?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 11%.

What is the Net Income forecast for United Therapeutics Corp?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 9%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett